On 19 December 2024, the FDA removed tirzepatide from its official drug shortage list, with semaglutide expected to follow in 2025 [3]
Contact your healthcare provider if gastrointestinal symptoms make it difficult to keep fluids down or if you notice dizziness, reduced urination, or unusual weakness
Finally, although the efficacy and safety of Ginseng has been evidenced in numerous clinical studies, additional well-designed, large-scale randomized control trials are needed
Many states are facing budgetary challenges, such as deficits, and are working to address the impacts of the changes to Medicaid and SNAP, Ferguson wrote, referring to the Supplemental Nutrition Assistance Program
Hasan at 3 and 6 months, either in person or virtually